Zydus Lifesciences Limited (ZYDUSLIFE) Financial Statements

8 Followers

Zydus Lifesciences Limited Financial Overview

Zydus Lifesciences Limited's market cap is currently ₹1.05T. The company's EPS TTM is ₹48.9; its P/E ratio is 17.39; and it has a dividend yield of 1.19%. Zydus Lifesciences Limited is scheduled to report earnings on May 19, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 271.48B	₹ 232.41B	₹ 195.47B	₹ 172.37B	₹ 151.10B
Gross Profit	₹ 140.30B	₹ 167.03B	₹ 131.54B	₹ 107.67B	₹ 94.24B
Operating Income	₹ 57.87B	₹ 96.04B	₹ 75.95B	₹ 57.61B	₹ 51.29B
EBITDA	₹ 71.95B	₹ 68.30B	₹ 52.57B	₹ 35.34B	₹ 31.70B
Net Income	₹ 50.40B	₹ 45.26B	₹ 38.59B	₹ 19.60B	₹ 44.87B
Balance Sheet
Cash & Short-Term Investments	₹ 71.92B	₹ 78.08B	₹ 13.58B	₹ 11.92B	₹ 35.05B
Total Assets	₹ 524.07B	₹ 372.02B	₹ 292.81B	₹ 257.56B	₹ 277.95B
Total Debt	₹ 124.96B	₹ 32.13B	₹ 8.04B	₹ 11.95B	₹ 42.21B
Net Debt	₹ 110.79B	₹ 2.56B	₹ 3.91B	₹ 7.07B	₹ 35.63B
Total Liabilities	₹ 228.24B	₹ 108.43B	₹ 71.79B	₹ 60.68B	₹ 87.42B
Stockholders' Equity	₹ 271.11B	₹ 239.53B	₹ 198.29B	₹ 175.16B	₹ 170.00B
Cash Flow
Free Cash Flow	₹ -12.03B	₹ 50.64B	₹ 23.21B	₹ 16.58B	₹ 9.02B
Operating Cash Flow	₹ 21.91B	₹ 67.77B	₹ 32.28B	₹ 26.89B	₹ 21.04B
Investing Cash Flow	₹ -87.25B	₹ -83.72B	₹ -14.75B	₹ 11.71B	₹ -10.00B
Financing Cash Flow	₹ 61.60B	₹ 20.14B	₹ -17.79B	₹ -44.00B	₹ -8.68B

Currency in INR

Zydus Lifesciences Limited Earnings and Revenue History

Income Statement >

Zydus Lifesciences Limited Debt to Assets

Balance Sheet >

Zydus Lifesciences Limited Cash Flow

Cash Flow >

Zydus Lifesciences Limited Forecast EPS vs Actual EPS

Earnings >